{"id":"https://openalex.org/W3208093465","doi":"https://doi.org/10.14309/01.ajg.0000776440.01416.18","title":"S727 Adalimumab Serum Levels in Relation to World Health Organization Standardization and Immunization in Clinical Gastroenterology Practice","display_name":"S727 Adalimumab Serum Levels in Relation to World Health Organization Standardization and Immunization in Clinical Gastroenterology Practice","publication_year":2021,"publication_date":"2021-10-01","ids":{"openalex":"https://openalex.org/W3208093465","doi":"https://doi.org/10.14309/01.ajg.0000776440.01416.18","mag":"3208093465"},"language":"en","primary_location":{"id":"doi:10.14309/01.ajg.0000776440.01416.18","doi":"https://doi.org/10.14309/01.ajg.0000776440.01416.18","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0000776440.01416.18","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013941544","display_name":"Judson McFarland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judson McFarland","raw_affiliation_strings":["Prometheus Laboratories, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023803968","display_name":"Hong Law","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hong Law","raw_affiliation_strings":["Prometheus Laboratories, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Schwalbe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Schwalbe","raw_affiliation_strings":["Prometheus Laboratories, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049463402","display_name":"Owen McLachlan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Owen McLachlan","raw_affiliation_strings":["Prometheus Laboratories, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063316824","display_name":"Jessica S. S. Ho","orcid":"https://orcid.org/0000-0003-2578-393X","observed_orcids":["https://orcid.org/0000-0003-2578-393X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica Ho","raw_affiliation_strings":["Prometheus Laboratories, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009375239","display_name":"Anjali Jain","orcid":"https://orcid.org/0000-0001-5658-367X","observed_orcids":["https://orcid.org/0000-0001-5658-367X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anjali Jain","raw_affiliation_strings":["Prometheus Laboratories, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073369495","display_name":"Thierry Dervieux","orcid":"https://orcid.org/0000-0002-3799-4438","observed_orcids":["https://orcid.org/0000-0002-3799-4438"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thierry Dervieux","raw_affiliation_strings":["Prometheus Laboratories, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, Inc., San Diego, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"116","issue":"1","first_page":"S332","last_page":"S332"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.5684000253677368,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.5684000253677368,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.3917999863624573,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.01940000057220459,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.9850000143051147},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.9430000185966492},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.7710000276565552},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.6230000257492065},{"id":"https://openalex.org/keywords/who-international-standard","display_name":"WHO International Standard","score":0.7699999809265137},{"id":"https://openalex.org/keywords/assay-calibration","display_name":"assay calibration","score":0.6539999842643738},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.4519999921321869},{"id":"https://openalex.org/keywords/serum-drug-levels","display_name":"serum drug concentration","score":0.5170000195503235},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.37599998712539673},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8853869438171387},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.7319860458374023},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5077437162399292},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4749096632003784},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45679357647895813},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.431686669588089},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3681347966194153},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.19584569334983826},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14309/01.ajg.0000776440.01416.18","doi":"https://doi.org/10.14309/01.ajg.0000776440.01416.18","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0000776440.01416.18","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/10","display_name":"Reduced inequalities","score":0.5099999904632568}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2978324288","https://openalex.org/W2115531366","https://openalex.org/W2585823178","https://openalex.org/W4249517836","https://openalex.org/W2043817429","https://openalex.org/W2129457078","https://openalex.org/W2977770134","https://openalex.org/W4389740531","https://openalex.org/W3139162955","https://openalex.org/W4207041762"],"abstract_inverted_index":{"Introduction:":[0],"Proactive":[1],"Therapeutic":[2],"drug":[3,55],"monitoring":[4],"(TDM)":[5],"of":[6,17,34,53,75,122,128,133,209,224,229,253,271,313,332,340,360],"Adalimumab":[7],"(ADA)":[8],"is":[9],"emerging":[10],"as":[11],"important":[12],"to":[13,29,113,193,335,348,351],"prevent":[14],"the":[15,31,35,42,51,72,230,311,333,343],"formation":[16,115],"Anti-Adalimumab":[18],"antibodies":[19],"(ATA)":[20],"in":[21,66,91,111,140,177,268,310,342,367,375],"inflammatory":[22],"bowel":[23],"diseases":[24],"(IBD).":[25],"Our":[26],"objective":[27],"was":[28,64,89,156],"evaluate":[30],"performance":[32],"characteristics":[33,359,374],"Homogenous":[36],"Mobility":[37],"Shift":[38],"Assay":[39],"(HMSA)":[40],"against":[41],"World":[43],"Health":[44],"Organization":[45],"(WHO)":[46],"international":[47],"standard":[48],"and":[49,99,131,162,171,298,378],"assess":[50],"impact":[52],"this":[54],"tolerant":[56],"assay":[57],"on":[58],"ADA":[59,83,94,109,168,180,211,223,242,263,280,349],"immunization.":[60],"Methods:":[61],"Data":[62],"collection":[63],"conducted":[65],"a":[67,119,207,249,323],"clinical":[68,123,344],"laboratory":[69],"accredited":[70],"by":[71,97,354],"American":[73],"College":[74],"Pathologists":[76],"using":[77,105,147,169,183,195],"liquid":[78],"chromatography":[79],"size":[80],"exclusion":[81],"HMSA.":[82],"WHO":[84,100,172,196,336],"Standard":[85],"(17/236)":[86],"lyophilized":[87],"powder":[88],"re-suspended":[90],"human":[92],"serum.":[93],"concentrations":[95],"measured":[96,167,182],"in-house":[98,170,184],"calibration":[101,185,197],"methods":[102],"were":[103,116,145,191],"compared":[104],"31":[106],"de-identified":[107,120],"specimens.":[108,124],"levels":[110,181,212,243,281],"relation":[112],"ATA":[114,141,234,254,308,320],"evaluated":[117],"from":[118,214],"database":[121],"Statistical":[125],"analysis":[126,130],"consisted":[127],"regression":[129],"determination":[132],"interval":[134,288],"likelihood":[135,270],"ratio":[136],"(ILR).":[137],"Longitudinal":[138],"changes":[139],"titers":[142,309],"(log":[143,282],"normalized)":[144],"analyzed":[146],"linear":[148],"mixed":[149,274],"effect":[150,275],"models.":[151],"Results:":[152],"Between":[153],"run":[154],"precision":[155],"6.2%":[157],"(median":[158],"CV;":[159],"range":[160],"3.1-12.5%)":[161],"4.2%":[163],"(range:":[164],"0.9-10.4%)":[165],"for":[166],"calibration,":[173],"respectively.":[174],"As":[175],"presented":[176],"Figure":[178],"1,":[179],"(mean":[186,198],"[SD]:":[187],"16.0\u00b19.7":[188],"\u00b5g/":[189],"mL)":[190],"comparable":[192],"those":[194],"15.9\u00b19.9":[199],"\u00b5g/ml)":[200],"(Deming\u2019s":[201],"slope":[202],"1.03":[203],"CI95%:":[204],"1.01-1.04).":[205],"In":[206,261],"population":[208],"84,540,":[210],"determined":[213],"61,491":[215],"subjects":[216],"(40\u00b117":[217],"years,":[218],"53%":[219],"female)":[220],"recovered":[221],"mean":[222,238],"10.0\u00b18.0":[225],"\u00b5g/mL":[226,246,266],"with":[227,248,306,316],"16.2%":[228],"patients":[231,314],"presenting":[232],"detectable":[233],"(":[235],">1.7":[236],"U/ml;":[237],"titer":[239],"1.9\u00b17.6":[240],"U/mL).":[241],"<":[244],"1.6":[245],"associated":[247,305],"9.9-fold":[250],"higher":[251],"probability":[252],"(ILR=9.85":[255],"CI":[256],"95%:":[257],"9.54-10.2)":[258],"(Table":[259],"1).":[260],"contrast,":[262],"exposure":[264],">10":[265],"resulted":[267],"negligible":[269],"ATA.":[272],"Linear":[273],"models":[276],"revealed":[277],"that":[278],"increasing":[279],"normal":[283],"estimate=-0.79\u00b10.01,":[284],"p<":[285,296,303],"0.01),":[286],"shorter":[287],"dosing":[289,326],"(weekly":[290],"vs.":[291],"every":[292],"other":[293],"week,":[294],"estimate=-0.06\u00b10.009,":[295],"0.001)":[297],"male":[299],"gender":[300],"(estimate=":[301],"0.05\u00b10.009,":[302],"0.002)":[304],"lower":[307],"subset":[312],"(n=9,875)":[315],"two":[317],"or":[318],"more":[319],"determinations":[321],"under":[322],"40":[324],"mg":[325],"regimen":[327],"(marginal":[328],"R2=0.26).":[329],"Conclusion:":[330],"Calibration":[331],"ADA-HMSA":[334],"may":[337],"facilitate":[338],"harmonization":[339],"TDM":[341],"gastroenterology":[345],"practice.":[346],"Immunization":[347],"appears":[350],"be":[352],"mitigated":[353],"optimized":[355],"exposure.Figure":[356],"1.:":[357,371],"Clinical":[358],"individuals,":[361],"immunosuppressants":[362],"&":[363],"biologic":[364],"agents":[365],"use":[366],"Ulcerative":[368],"Colitis":[369],"(UC).Table":[370],"Selected":[372],"baseline":[373],"weighted*":[376],"ustekinumab":[377],"adalimumab":[379],"cohorts.":[380]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2021-11-08T00:00:00"}